Biosimilar manufacturers form group to influence market in U.S.

Nearly a dozen makers of biosimilars, including Hospira ($HSP), Pfizer ($PFE), Samsung and Sandoz, have banded together into the Biosimilars Forum, a nonprofit group that will lobby for how biosimilars are used in the U.S. The move comes as the FDA has a number of biosimilars under consideration, approvals of which will start biosimilar use in the U.S. Release

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

CDMO Sterling Pharma Solutions is plotting a buyout of a U.K.-based antibody-drug conjugate specialist in a new bid at the next-gen cancer fighters.

Lonza will build two new manufacturing suites at its Visp, Switzerland site to handle antibody-drug conjugates for an unnamed customer.